Pinson Roxanne, Sotoodian Bahman, Fiorillo Loretta
School of Medicine.
Division of Dermatology and Cutaneous Sciences, Department of Medicine.
Psoriasis (Auckl). 2016 Oct 20;6:121-129. doi: 10.2147/PTT.S87650. eCollection 2016.
The clinical presentation, disease associations, and diverse treatment modalities in overcoming the challenges of managing pediatric psoriasis have been extensively summarized in this article. An extensive literature review revealed the differences in presentation of psoriasis during infancy, childhood, and adolescence. We also summarized the latest topical, systemic, and biological modalities in treating recalcitrant psoriasis. The association of psoriasis with juvenile arthritis and obesity and the significant influence of the disease on the children's quality of life were explored. The clinical presentation of psoriasis can evolve during the child's lifespan. While many treatment modalities already exist for treating pediatric psoriasis, some of the new biologics that are approved for adult patients have not been investigated in the pediatric population and no algorithm exists for their use in this population. Large clinical studies in the future will enhance our understanding with regards to their safety and potential implications in pediatric populations.
本文广泛总结了小儿银屑病管理挑战方面的临床表现、疾病关联及多种治疗方式。广泛的文献综述揭示了婴儿期、儿童期和青少年期银屑病表现的差异。我们还总结了治疗顽固性银屑病的最新局部、全身和生物治疗方式。探讨了银屑病与青少年关节炎和肥胖的关联以及该疾病对儿童生活质量的重大影响。银屑病的临床表现可能在儿童的整个生命周期中发生变化。虽然已经有许多治疗小儿银屑病的方法,但一些已获批用于成人患者的新型生物制剂尚未在儿科人群中进行研究,且在该人群中也不存在使用这些生物制剂的算法。未来的大型临床研究将增进我们对其在儿科人群中的安全性和潜在影响的理解。